In questo numero: New frontiers of immunotherapy in non-melanoma skin cancers...

leggi online | #137 - 12/2018

Paolo Ascierto e Dirk Schadendorf al simposio “Immunotherapy in non-melanoma skin cancer: updates and new perspective”.

Which links between immunity, inflammation and cancer? What are the implications for clinical practice? We interviewed Alberto Mantovani at “Immunotherapy Bridge”.
 

Lisa H. Butterfield, President of the Society of ImmunoTherapy of Cancer (SITC), makes an assessment of the two days of “Immunotherapy Bridge” congress.

Vaccines targeting a new class of cancer antigens, combined with T cell agonists and checkpoint blockers: we talked about it with Bernard A. Fox.

UNA PUBBLICAZIONE DE IL PENSIERO SCIENTIFICO EDITORE
ISSN 2385-0108

non voglio più ricevere oncoinfo

 

oncoinfo.it 2018 © Think2it | All rights reserved